Needham Investment Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-15,000
Closed -$354K 101
2017
Q1
$354K Hold
15,000
0.09% 91
2016
Q4
$200K Buy
+15,000
New +$242K 0.05% 98
2015
Q4
Sell
-15,000
Closed -$270K 101
2015
Q3
$270K Hold
15,000
0.07% 95
2015
Q2
$446K Buy
15,000
+5,000
+50% +$126K 0.1% 89
2015
Q1
$220K Hold
10,000
0.05% 103
2014
Q4
$274K Sell
10,000
-8,500
-46% -$207K 0.06% 104
2014
Q3
$358K Hold
18,500
0.08% 100
2014
Q2
$315K Hold
18,500
0.07% 107
2014
Q1
$262K Buy
+18,500
New +$250K 0.06% 106

Other funds holding EXAS

Needham Investment Management's EXAS Position: Q2 2017 in Review

Needham Investment Management sold out of Exact Sciences (EXAS) in Q2 2017, closing a stake of 15,000 shares — an estimated $354K sold.

Needham Investment Management first reported a position in EXAS in Q1 2014 and held it in 9 quarters. The position peaked at $446K in Q2 2015. 266 funds tracked by Wall St. Rank hold EXAS as of Q2 2017.

  • Needham Investment Management reported no remaining Exact Sciences position as of Q2 2017 after selling out during the quarter.
  • Needham Investment Management sold 15,000 Exact Sciences shares in Q2 2017, an estimated $354K.
  • Needham Investment Management first reported a position in Exact Sciences in Q1 2014 and held it in 9 quarters.
  • Needham Investment Management's Exact Sciences position peaked at $446K in Q2 2015.
  • 266 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2017.

Based on Needham Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.